Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials
In other recent news, Avantor Inc . has faced several adjustments in analyst ratings and price targets following its latest earnings report. Goldman Sachs downgraded Avantor’s stock from ’Buy’ to ’Neutral’ and slashed its price target to $14.00, citing concerns over the Laboratory Solutions segment’s growth potential. Bernstein also lowered its price target to $15.00, maintaining a Market Perform rating due to disappointing first-quarter results and increased market competition. RBC Capital reduced its price target to $20.00 but maintained an Outperform rating, expressing optimism about Avantor’s long-term prospects despite current challenges. TD Cowen downgraded the stock to ’Hold’ with a new target of $15.50, reflecting concerns over near-term growth and margin outlook. Morgan Stanley (NYSE:MS) also downgraded Avantor to ’Equalweight’ and cut the price target to $15.00, highlighting competitive pressures and potential downside risks. These recent developments suggest a cautious outlook among analysts as Avantor navigates competitive and macroeconomic headwinds.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.